Preventing relapse in alcohol disorder with EEG-neurofeedback as a neuromodulation technique: A review and new insights regarding its application
- PMID: 32197211
- DOI: 10.1016/j.addbeh.2020.106391
Preventing relapse in alcohol disorder with EEG-neurofeedback as a neuromodulation technique: A review and new insights regarding its application
Abstract
Alcohol Use Disorder (AUD) has a disconcertingly high relapse rate (70-80% within a year following withdrawal). Preventing relapse or minimizing its extent is hence a challenging goal for long-term successful management of AUD. New perspectives that rely on diverse neuromodulation tools have been developed in this regard as care supports. This paper focuses on electroencephalogram-neurofeedback (EEG-NF), which is a tool that has experienced renewed interest in both clinical and research areas. We review the literature on EEG-based neurofeedback studies investigating the efficacy in AUD and including at least 10 neurofeedback training sessions. As neurofeedback is a form of biofeedback in which a measure of brain activity is provided as feedback in real-time to a subject, the high degree of temporal resolution of the EEG interface supports optimal learning. By offering a wide range of brain oscillation targets (alpha, beta, theta, delta, gamma, and SMR) the EEG-NF procedure increases the scope of possible investigations through a multitude of experimental protocols that can be considered to reinforce or inhibit specific forms of EEG activity associated with AUD-related cognitive impairments. The present review provides an overview of the EEG-NF protocols that have been used in AUD and it highlights the current paucity of robust evidence. Within this framework, this review presents the arguments in favor of the application of EEG-NF as an add-on tool in the management of alcohol disorders to enhance the cognitive abilities required to maintain abstinence more specifically, with a focus on inhibition and attentional skills.
Keywords: Alcohol Use Disorder (AUD); Attention; Dual process model; EEG; Inhibition; Neurofeedback.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Electroencephalographic neurofeedback as a tool for reducing harm and risk associated with alcohol use disorder: A critical review.Drug Alcohol Rev. 2022 Mar;41(3):594-602. doi: 10.1111/dar.13387. Epub 2021 Sep 27. Drug Alcohol Rev. 2022. PMID: 34580941 Review.
-
Neurofeedback training aimed to improve focused attention and alertness in children with ADHD: a study of relative power of EEG rhythms using custom-made software application.Clin EEG Neurosci. 2013 Jul;44(3):193-202. doi: 10.1177/1550059412458262. Clin EEG Neurosci. 2013. PMID: 23820311
-
Specific or nonspecific? Evaluation of band, baseline, and cognitive specificity of sensorimotor rhythm- and gamma-based neurofeedback.Int J Psychophysiol. 2017 Oct;120:1-13. doi: 10.1016/j.ijpsycho.2017.06.005. Epub 2017 Jun 24. Int J Psychophysiol. 2017. PMID: 28652143
-
Self-Modulation of Gamma-Band Synchronization through EEG-Neurofeedback Training in the Elderly.J Integr Neurosci. 2024 Mar 21;23(3):67. doi: 10.31083/j.jin2303067. J Integr Neurosci. 2024. PMID: 38538229 Clinical Trial.
-
The efficacy of neurofeedback for alcohol use disorders - a systematic review.World J Biol Psychiatry. 2023 Jun-Jul;24(6):496-507. doi: 10.1080/15622975.2022.2151043. Epub 2022 Dec 6. World J Biol Psychiatry. 2023. PMID: 36416049
Cited by
-
Excitation and polarization of isolated neurons by high-frequency sine waves for temporal interference stimulation.Cell Rep Phys Sci. 2025 Jul 16;6(7):102660. doi: 10.1016/j.xcrp.2025.102660. Epub 2025 Jun 16. Cell Rep Phys Sci. 2025. PMID: 40762005 Free PMC article.
-
Infra-Low Frequency Neurofeedback in the Treatment of Patients With Chronic Eating Disorder and Comorbid Post-Traumatic Stress Disorder.Front Hum Neurosci. 2022 May 6;16:890682. doi: 10.3389/fnhum.2022.890682. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35601900 Free PMC article.
-
Clinical Efficacy of Atomoxetine Hydrochloride Combined with Electroencephalogram Biofeedback in Attention-Deficit/Hyperactivity Disorder in Children.eNeuro. 2025 Apr 1;12(4):ENEURO.0371-24.2025. doi: 10.1523/ENEURO.0371-24.2025. Print 2025 Apr. eNeuro. 2025. PMID: 40107719 Free PMC article. Clinical Trial.
-
Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial.J Psychiatry Neurosci. 2022 Jun 15;47(3):E222-E229. doi: 10.1503/jpn.210202. Print 2022 May-Jun. J Psychiatry Neurosci. 2022. PMID: 35705204 Free PMC article. Clinical Trial.
-
The role of the orbitofrontal cortex and the nucleus accumbens for craving in alcohol use disorder.Transl Psychiatry. 2021 May 4;11(1):267. doi: 10.1038/s41398-021-01384-w. Transl Psychiatry. 2021. PMID: 33947835 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials